Mycophenolate mofetil treatment of myasthenia gravis

Annals of Pharmacotherapy

Volumn 40, Issue 2, 2006, Pages 295-298

  Cahoon Jr , William D ^a   Kockler, Denise R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Myasthenia gravis; Mycophenolate

Indexed keywords

AZATHIOPRINE; CHOLINESTERASE INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PYRIDOSTIGMINE; STEROID;

AUTOIMMUNE DISEASE; B LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUPUS ERYTHEMATOSUS; LYMPHOCYTE PROLIFERATION; MYASTHENIA GRAVIS; NAUSEA; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC VASCULITIS; T LYMPHOCYTE; VOMITING;

CLINICAL TRIALS; DATABASES, FACTUAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MEDLINE; MYASTHENIA GRAVIS; MYCOPHENOLIC ACID; TREATMENT OUTCOME;

EID: 33144475027     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1G501     Document Type: Review

References (24)

1. Phillips LH. The epidemiology of myasthenia gravis. Semin Neurol 2004;24:17-20.
2. Howard JF. Myasthenia gravis - a summary. Myasthenia Gravis Foundation of America. www.myasthenia.org/information/summary.htm (accessed 2005 Aug 3).
3. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet 2001;357:2122-8.
4. Drachman DB. Myasthenia gravis. N Engl J Med 1994;330:1797-810.
5. Levinson AI, Song D, Gaulton O, Zheng Y. The intrathymic pathogenesis of myasthenia gravis. Clin Dev Immunol 2004;11:215-20.
6. Nicolle MW. Myasthenia gravis. Neurologist 2002;8:2-21.
7. Pinching AJ, Peters DK, Newsom-Davis J. Remission of myasthenia gravis following plasma-exchange. Lancet 1976;2:1373-6.
8. Keesey J, Buffkin D, Kebo D, Ho W, Herrmann C Jr. Plasma exchange alone as therapy for myasthenia gravis. Ann N Y Acad Sci 1981;377:729-43.
9. Dwyer JM. Manipulating the immune system with immune globulin. N Engl J Med 1992;326:107-16.
10. Ciafaloni E. Mycophenolate mofetil and myasthenia gravis. Lupus 2005;14(suppl):S46-9.
11. Richman DP, Agius MA. Treatment of autoimmune myasthenia gravis. Neurology 2003;61:1652-61.
12. Lewis RA, Sewla JF, Lisak RP. Myasthenia gravis: immunological mechanisms and immunotherapy. Ann Neurol 1995;37(suppl 1):S51-62.
13. Product information. Cellcept (mycophenolate mofetil). Nutley, NJ: Roche, October 2004.
14. Allison AC. Mechanisms of action of mycophenolate mofetil. Lupus 2005;14(suppl):S2-8.
15. Gaubitz M, Schorat A, Schotte H, Kern P, Domschke W. Mycophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial. Lupus 1999;8:731-6.
16. Schiff MH, Goldblum R, Rees MMC. 2-Morpholino-ethyl mycophenolic acid (ME-MPA) in the treatment of refractory rheumatoid arthritis (RA) (abstract). Arthritis Rheum 1990;33(suppl 9):S155.
17. McMurray RW, Elbourne KB, Lal S. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet 1997;349:774.
18. Hauser RA, Malek AR, Rosen R. Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil. Neurology 1998;51:912-3.
19. Meriggioli MN, Rowin J. Treatment of myasthenia gravis with mycophenolate mofetil: a case report. Muscle Nerve 2000;23:1287-9.
20. Chaudry V, Cornblath DR, Griffin JW, O'Brien R, Drachman DB. Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases. Neurology 2001;56:94-6.
21. Meriggioli MN, Ciafaloni E, Al-Hayk KA, et al. Mycophenolate mofetil for myasthenia gravis. Neurology 2003;61:1438-40.
22. Ciafaloni E, Massey JM, Tucker-Lipscomb B, Sanders DB. Mycophenolate mofetil for myasthenia gravis: an open-label pilot study. Neurology 2001;56:97-9.
23. Meriggioli MN, Rowin J, Richman JO, Leurgans S. Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study. Ann N Y Acad Sci 2003;998:494-9.
24. Barohn RJ, McIntire D, Herbelin L, Wolfe GI, Nations S, Bryan WW. Reliability testing of the quantitative myasthenia gravis score. Ann N Y Acad Sci 1998;841:769-72.